Cawachi Limited

Equities

2664

JP3226450009

Drug Retailers

Market Closed - Japan Exchange 02:00:00 2024-05-02 am EDT 5-day change 1st Jan Change
2,802 JPY +0.36% Intraday chart for Cawachi Limited +7.56% +5.58%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cawachi Limited Provides Consolidated Earnings Guidance for the Six Months Ending September 2024 and Year Ending March 2025 CI
Cawachi’s Attributable Profit Up 4.8% in Fiscal Nine Months on Marginal Growth in Sales MT
Cawachi Limited Provides Consolidated Earnings Guidance for the Period Ending March 2024 CI
Cawachi Limited Provides Earnings Guidance for the Quarter Ending March 31, 2024 CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Six Months Ending September 2023 and Full Year Ending March 2024 CI
Cawachi Limited Provides Earnings Guidance for the Interim Period Ended September 2023 and Full Year Ended March 2024 CI
Cawachi Limited Provides Consolidated Earnings Guidance for Year Ending March 15, 2023 CI
Cawachi Limited Provides Consolidated Earnings Guidance for Year Ending March 2023 CI
Cawachi Limited Provides Earnings Guidance for the Six Months Ending September 2022 and Year Ending March 15, 2023 CI
Cawachi Limited Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending March 15, 2023 CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Year Ending March 15, 2023 CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Year Ending March 15, 2022 CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Year Ending March 15, 2022 CI
Cawachi Limited Announces Consolidated Earnings Results for the First Quarter Ended June 15, 2021 CI
Cawachi Limited Provides Earnings Guidance for the Six Months Ending September 15, 2021 and Year Ending March 15,2022 CI
Cawachi Limited Reports Consolidated and Non-Consolidated Earnings Results for the Fiscal Year Ended March 15, 2021 CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2022 CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Year Ending March 31, 2021 CI
Cawachi Limited Reports Consolidated Earnings Results for the Third Quarter Ended December 31, 2020 CI
Cawachi Limited Announces Consolidated Earnings Results for the Second Quarter Ended September 30, 2020 CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2021 CI
Cawachi Limited Announces Earnings Results for the First Quarter Ended June 30, 2020 CI
Cawachi Limited Provides Earnings Guidance for the Six Months Ending September 2020 and Year Ending March 31, 2021 CI
Cawachi Limited Announces Consolidated and Non- Consolidated Earnings Result for the Year Ended March 15, 2020; Provides Consolidated Earnings Guidance for the First Half and Fiscal Full Year Ending March 15, 2021 CI
Cawachi Limited Reports Consolidated Earnings Results for the Third Quarter Ended December 2019; Provides Consolidated Earnings Guidance for the Quarter Ending March 2020 CI
Chart Cawachi Limited
More charts
CAWACHI LIMITED is a Japan-based company engaged in the operation of drugstores. The Company sells pharmaceutical products, including cold medicines, digestive medicines, various vitamin tablets, eye drops and nursing care items; cosmetics, including basic skin care products, makeup products and cosmetics for men; miscellaneous goods, including detergents, toilet papers, pet items and milk powders, as well as food products, including processed food products, dairy products, confectioneries, beverages and alcohol through its drugstores.
More about the company
  1. Stock Market
  2. Equities
  3. 2664 Stock
  4. News Cawachi Limited
  5. Cawachi’s Attributable Profit Up 4.8% in Fiscal Nine Months on Marginal Growth in Sales